Back to dashboard
All PlansAdministrativeLow impact

Voluntary nationwide recall: Cyclosporine

UPMC Health Plan·Nephrology, Gastroenterology, Cardiology +2 more·Pharmacy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Novartis has issued a voluntary nationwide recall of one lot of Sandimmune Oral solution (cyclosporine) due to crystal formation in some bottles. This medication is used to prevent organ rejection in kidney, liver, and heart transplants.

Action Required

Action needed
Immediately: Clinical staff should check inventory for the recalled lot of Sandimmune Oral solution (cyclosporine oral solution, USP), 100 mg/mL and remove from use. Contact patients currently prescribed this specific lot to arrange alternative dosing or replacement medication. Review the full recall text for lot identification details.